ecopipam has been researched along with Schizophrenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farde, L; Härnryd, C; Karlsson, P; Sedvall, G; Smith, L; Wiesel, FA | 1 |
| Barnes, TR; de Beaurepaire, R; Jones, BD; Labelle, A; Naber, D | 1 |
2 trial(s) available for ecopipam and Schizophrenia
| Article | Year |
|---|---|
Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients.
Topics: Adult; Benzazepines; Brief Psychiatric Rating Scale; Dopamine Antagonists; Female; Humans; Male; Middle Aged; Receptors, Dopamine D1; Schizophrenia; Time Factors | 1995 |
An open trial of the D1 antagonist SCH 39166 in six cases of acute psychotic states.
Topics: Adult; Benzazepines; Brief Psychiatric Rating Scale; Dopamine Antagonists; Humans; Male; Middle Aged; Psychotic Disorders; Receptors, Dopamine D1; Schizophrenia; Time Factors; Treatment Outcome | 1995 |